Influenza A (H3N2) outbreak, Nepal

Emerging Infectious Diseases

Volumn 11, Issue 8, 2005, Pages 1186-1191

  Daum, Luke T ^a,b   Shaw, Michael W ^c   Klimov, Alexander I ^c   Canas, Linda C ^a   Macias, Elizabeth A ^a   Niemeyer, Debra ^a   Chambers, James P ^b   Renthal, Robert ^b   Shrestha, Sanjaya K ^d   Acharya, Ramesh P ^e   Huzdar, Shankar P ^e   Rimal, Nirmal ^e   Myint, Khin S ^f   Gould, Philip ^a  

^a Air Force Materiel Command   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Walter Reed Armed Forces Research Institute of Medical Sciences   (Nepal)

^e Association of Medical Doctors of Asia Nepal   (Nepal)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; INFLUENZA VACCINE; ISOLEUCINE; LYSINE; PROLINE; SERINE; VALINE; VIRUS HEMAGGLUTININ; VIRUS RNA;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY COMBINING SITE; ARTICLE; BHUTAN; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; GLYCOSYLATION; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOASSAY; INFLUENZA VIRUS A; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEPAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REFUGEE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; THROAT CULTURE; VIRUS ISOLATION; VIRUS STRAIN;

EID: 22944432837     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1108.050302     Document Type: Article

References (20)

1. CDC influenza weekly report: influenza summary update, questions and answers, the 2003-2004 influenza season. [cited 19 May 2005]. Available from http: www.cdc.gov/flu/about/qa/fluseason.htm
2. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2004;53:1-40.
3. Webster RG, Kendal, AP, Gerhard W. Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology. 1979;96:258-64.
4. Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 1981;289:373-8.
5. Wilson AI, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990;8:737-71.
6. Lee MS, Chen JS. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis. 2004;10:1385-90.
7. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science. 1999;286:1921-5.
8. Plotkin JB, Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A. 2003;100:7152-7.
9. Canas LC, Lohman K, Pavlin JA, Endy T, Singh DL, Pandey P, et al. The Department of Defense laboratory-based global influenza surveillance system. Mil Med. 2000;165(Suppl 2):52-6.
10. Daum LT, Canas LC, Smith CB, Klimov A, Huff WB, Barnes WJ, et al. Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis. 2002;8:408-12.
11. Kendal AP, Pereura MS, Skehel J. Concepts and procedures for laboratory based influenza surveillance. Geneva: World Health Organization; 1982.
12. Koradi R, Billeter M, Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph. 1996;14:29-32, 51-55.
13. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling, Electrophoresis. 18;2714-23.
14. Cross KJ, Burleigh LM, Steinhauer DA. Mechanisms of cell entry by influenza virus. Expert Rev Mol Med. 2001;6:1-18.
15. Wilson IA, Ladner, RC, Skehel, Wiley DC. The structure and role of the carbohydrate moieties of influenza virus hemagglutinin. Biochem Soc Trans. 1983;11:145-7.
16. Hughey PG, Roberts PC, Holsinger LJ, Zebedee SL, Lamb RA, Compans RW. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology. 1995;212:411-21.
17. Zebedee SL, Lamb RA. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988;62:2762-72.
18. Webster RG, Brown LE, Laver WG. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies. Virology. 1984;135:30-42.
19. Okuno Y, Isegawa Y, Sasao F, Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol. 1993;67:2552-8.
20. CDC weekly report: influenza summary update (week ending April 16, 2005). [cited 19 May 2005]. Available from http://www. cdc.gov/flu/weekly/